Numerous attempts have been made to improve the EPR-mediated tumor targeting by modulation of tumor vessel permeability using both pharmacological strategies (e.g., combination chemotherapy with nitric oxide donors or VEGF agonists and antagonists) and physical methods (e.g., ultrasound or hyperthermia) (reviewed in [2,4,16]). Here, VEGFA is linked to neoplasm.